XM does not provide services to residents of the United States of America.
G
G

GoldmSachs

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

Payments processor NCR Voyix explores sale of digital banking unit, sources say

Payments processor NCR Voyix explores sale of digital banking unit, sources say By Milana Vinn and David French NEW YORK, July 5 (Reuters) - Payments processor NCR Voyix VYX.N is exploring the sale of its digital banking business which it hopes will fetch as much as $3 billion, people familiar with the matter said. Atlanta, Georgia-based NCR Voyix has tapped Goldman Sachs GS.N to solicit interest from potential buyers, which include private equity firms and other payments processors, said the so
G

Megacaps push Nasdaq, S&P 500 to record highs after payrolls data

US STOCKS-Megacaps push Nasdaq, S&P 500 to record highs after payrolls data For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Fed rate cut debate in view as U.S. job market cools S&P 500 tech sector hits record high All three major indexes set for weekly gains Macy's up on report Arkhouse, Brigade Capital raise buyout offer Indexes: Dow flat, S&P up 0.34%, Nasdaq up 0.79% Updated at 12:14 p.m.
A
A
G
M
U
U

US banks fall after jobs data

BUZZ-US banks fall after jobs data ** Shares of U.S. banks fall after jobs data shows labor market cooling off ** JPMorgan Chase JPM.N , Bank of America BAC.N , Wells Fargo WFC.N and Citigroup C.N down between 1% and 2.3% ** The S&P 500 banks index .SPXBK fell 1.7% ** Annual wages increased at the slowest pace in three years and unemployment rate r
C
G
J
U

Brokerages lift S&P 500 target on hopes for soft landing, rate cuts

FACTBOX-Brokerages lift S&P 500 target on hopes for soft landing, rate cuts Updates to add J.P. Morgan's real GDP growth figures for U.S. and UK, Goldman Sachs U.S. inflation figures and US 10-year yield target July 5 (Reuters) - Brokerages have raised their year-end targets for the U.S. stocks benchmark S&P 500 .SPX , spurred by expectations of a "soft landing" for the economy and growing odds the Federal Reserve will cut interest rates this year.
B
C
D
E
G
J
U
U
U

Bain-backed Emcure Pharma's $234 mln India IPO draws $11 bln in bids

Bain-backed Emcure Pharma's $234 mln India IPO draws $11 bln in bids By VarunVyas Hebbalalu and Kashish Tandon BENGALURU, July 5 (Reuters) - India's Emcure Pharmaceuticals EMCU.NS drew strong interest for its $234 million initial public offering (IPO) as investors bet on its slate of women's healthcare and HIV treatments to drive growth in a high-margin market.
A
G

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.